Trudeau’s path back to glory

Parliament’s return could mark the moment the Liberals turn things around.
It’s time to step up on housing to get more homes built

Canada has the most expensive housing market and lowest housing stock per capita among G7 nations.
Green caucus priorities include congruently addressing climate and housing crisis

Failure to act on the climate emergency increases our costs, from extreme weather events costing billions of dollars each year, to inflation driven in part by climate events that destroy crops and reduce yields.
Bills on gun control, digital privacy, and Métis governments among business in busy fall for Parliamentary committees

House and Senate committees will be reviewing bills related to the overhaul of federal privacy laws, the carbon price on farm fuel, and the seizure of dangerous drugs in the postal system.
How summer shaped the fall sitting: old issues with new focus, and shifting party dynamics

While the key policy themes in Parliament are largely unchanged from June to September, some will re-emerge in autumn with sharper or more urgent focus.
Talent shortage a priority for biotech sector emerging from pandemic

Canada is likely to face a shortfall of about 65,000 workers in the bio-economy by 2029, according to BioTalent Canada.
Canada’s place in the world of biotechnology research and application is in jeopardy

Government of Canada funded scholarships and fellowships are the primary sources of income for many biotechnology researchers. To stem the brain-drain, Canada must significantly increase the value and number of graduate student scholarships and post-doctoral fellowships and to index them to the cost of living.
Can biotechnology put patients’ needs ahead of profits?

These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that ‘waxed lyrical’ about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.
Seizing the moment: building Canada’s academic leadership into a commercial powerhouse
Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
New safety guidance sets up corporate self-regulation of GMOs

Health Canada and the Canadian Food Inspection Agency both recently updated their guidance on regulating genetically engineered foods and seeds.